Saamya Biotech (India) Limited announced unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company's loss from operations before other income, interest & exceptional items was INR 762,494 against profit from operations before other income, interest & exceptional items was INR 2,543,060 a year ago. Loss from ordinary activities before tax was INR 805,612 against profit from ordinary activities before tax was INR 2,513,938 a year ago. Net loss was INR 733,567 or INR 0.03 basic and diluted EPS after extraordinary items against Net profit was INR 1,721,913 or INR 0.07 basic and diluted EPS after extraordinary items a year ago.

For the nine months, the company's net sales were INR 29,824,673 against INR 176,256,060 a year ago. Loss from operations before other income, interest & exceptional items was INR 1,413,862 against profit from operations before other income, interest & exceptional items was INR 4,520,158 a year ago. Loss from ordinary activities before tax was INR 1,639,917 against profit from ordinary activities before tax was INR 4,342,966 a year ago. Net loss was INR 1,673,052 or INR 0.07 basic and diluted EPS after extraordinary items against Net profit was INR 3,016,209 or INR 0.12 basic and diluted EPS after extraordinary items a year ago.